Actualité

Immunopathological manifestations in Kabuki syndrome

  • Recherche,
  • Santé-Sciences-Technologie,
  • Santé-social,
Date(s)

le 20 septembre 2019

Published in Genet Med

Projet de recherche collaborative dirigé par le Prof. D. Geneviève (Inserm U1183, Université de Montpellier, Montpellier, France) auquel le Prof. A. Toutain a participé

Immunopathological manifestations in Kabuki syndrome: a registry study of 177 individuals

Abstract

PURPOSE: Kabuki syndrome (KS) (OMIM 147920 and 300867) is a rare genetic disorder characterized by specific facial features, intellectual disability, and various malformations. Immunopathological manifestations seem prevalent and increase the morbimortality. To assess the frequency and severity of the manifestations, we measured the prevalence of immunopathological manifestations as well as genotype-phenotype correlations in KS individuals from a registry.

METHODS: Data were for 177 KS individuals with KDM6A or KMT2D pathogenic variants. Questionnaires to clinicians were used to assess the presence of immunodeficiency and autoimmune diseases both on a clinical and biological basis.

RESULTS: Overall, 44.1% (78/177) and 58.2% (46/79) of KS individuals exhibited infection susceptibility and hypogammaglobulinemia, respectively; 13.6% (24/177) had autoimmune disease (AID; 25.6% [11/43] in adults), 5.6% (10/177) with ≥2 AID manifestations. The most frequent AID manifestations were immune thrombocytopenic purpura (7.3% [13/177]) and autoimmune hemolytic anemia (4.0% [7/177]). Among nonhematological manifestations, vitiligo was frequent. Immune thrombocytopenic purpura was frequent with missense versus other types of variants (p = 0.027).

CONCLUSION: The high prevalence of immunopathological manifestations in KS demonstrates the importance of systematic screening and efficient preventive management of these treatable and sometimes life-threatening conditions.

Keywords

#KDM6A; #KMT2D; #Kabuki syndrome; #immunity

Contact :
Prof. Annick Toutain :